Reme-D
Cairo molecular diagnostics company founded in 2023 that develops and manufactures affordable nucleic-acid extraction and amplification kits for infectious and non-communicable diseases including tuberculosis, HIV, hepatitis and HPV; its kits stay stable at ambient temperature, removing cold-chain dependence for low-resource settings.
Headquarters
Cairo, Egypt
Year Founded
2023
Founders
Salma Tammam (founder)
Country
Egypt
Financial Information
Funding Stage
Pre-Series A
Recent Funding
$1.45M
Funding By
Anara Impact Capital, Global Innovation Fund, Africa Health Ventures
Core Technology
Room-temperature-stable nucleic acid extraction and amplification chemistry
Product Type
Diagnostic
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Not disclosed
Partnerships
Pharma Collaborations
Not disclosed
Academic / Hospital Tie-ups
Not disclosed
CRO/CDMO Partnerships
In-house manufacturing
Market & Differentiation
Cold-chain-free diagnostics designed for African health systems and decentralised testing